Brivaracetam, Serum/Plasma
BRVCTM
Test Summary
Therapeutic drug monitoring.
Aliases
Briviact®
Specimen Collection
Special Instructions
N/A
Preferred Specimen
1 mL serum from red top rube
Minimum Volume
0.2 mL
Instructions
Promptly centrifuge and separate serum or plasma into a plastic screw capped vial.
Patient Preparation
N/A
Storage
Plastic pour off tube
Transport Temperature
Refrigerated
Specimen Stability
- Room Temperature: 30 days
- Refrigerated: 30 days
- Frozen: -20°C 4 months
Limitations
N/A
Other Acceptable Specimens
Plasma from EDTA (lavender top) tube
Unacceptable Specimens
Polymer gel separation tube (SST or PST)
Order Code
BRVCTM
EPIC (Premier) Code
LAB7040
Includes
N/A
CPT Code
80375
Billing Code
671407
CPT Statement
Methodology
High-Performance Liquid Chromatography/Tandem Mass Spectrometry (LC-MS-MS)
FDA Status
This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration.
Physician Attestation of Informed Consent
N/A
Testing Laboratory
3701 WELSH ROAD
Willow Grove PA, 19090
Department
Reference Range
See Report
Setup Schedule / Expected Turnaround Time
Varies; Report available: 4 - 8 days
Specimen Collection
Special Instructions
N/A
Preferred Specimen
1 mL serum from red top rube
Minimum Volume
0.2 mL
Instructions
Promptly centrifuge and separate serum or plasma into a plastic screw capped vial.
Patient Preparation
N/A
Storage
Plastic pour off tube
Transport Temperature
Refrigerated
Specimen Stability
- Room Temperature: 30 days
- Refrigerated: 30 days
- Frozen: -20°C 4 months
Limitations
N/A
Other Acceptable Specimens
Plasma from EDTA (lavender top) tube
Unacceptable Specimens
Polymer gel separation tube (SST or PST)
Result Information
Methodology
High-Performance Liquid Chromatography/Tandem Mass Spectrometry (LC-MS-MS)
Testing Laboratory
Reference Range
See Report
Setup Schedule / Expected Turnaround Time
Varies; Report available: 4 - 8 days